Home > Healthcare & Medical Devices > Active Pharmaceutical Ingredients Market > Table of Contents
Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Active Pharmaceutical Ingredients industry 3600 synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Therapeutic category trends
2.1.3 Synthesis type trends
2.1.4 Contract outsourcing type trends
2.1.5 Application trends
2.1.6 Drug type trends
2.1.7 Regional trends
Chapter 3 Active Pharmaceutical Ingredients Industry Insights
3.1 Industry landscape, 2018-2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of chronic diseases
3.2.1.2 Rising drug research and development activities
3.2.1.3 Increasing demand for generics
3.2.1.4 Increasing uptake of biopharmaceuticals
3.2.2 Industry pitfalls & challenges
3.2.2.1 Unfavourable drug price control policies
3.2.2.2 High manufacturing costs
3.3 Growth potential analysis
3.3.1 By therapeutic category trends
3.3.2 By synthesis type trends
3.3.3 By contract outsourcing type trends
3.3.4 By application trends
3.3.5 By drug type trends
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Supply chain analysis
3.7 key market trends
3.8 Pipeline analysis
3.9 Regulatory landscape
3.9.1 U.S.
3.9.2 Europe
3.9.3 Asia Pacific
3.10 Vendor matrix analysis
3.11 API manufacturing trends
3.12 Overview of API Production
3.12.1 Share of supply in (%) Total European Demand in Tons
3.12.2 Overview of CEPS, APIs and Manufacturers By Region (2000-2020)
3.12.3 Overview of development of the number of valid CEPS (2000 -2020)
3.12.4 Overview of global distribution of currently valid CEPS (2020)
3.12.5 Analyst insights
3.13 Policy landscape
3.13.1 China
3.13.2 India
3.14 Porter's analysis
3.15 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021
4.4 Strategy landscape
Chapter 5 Active Pharmaceutical Ingredients Market, By Therapeutic Category
5.1 Key therapeutic category trends
5.2 Oncology
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Infectious diseases
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Anti-diabetics
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 CNS & anesthesia
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6 Cardiovascular diseases
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.7 Biologics
5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.8 Others
5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Active Pharmaceutical Ingredients Market, By Synthesis Type
6.1 Key synthesis type trends
6.2 Chemical based API
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Biological API
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Highly potent API (HPAPI)
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Active Pharmaceutical Ingredients Market, By Contract Outsourcing Type
7.1 Key contract outsourcing type trends
7.2 CDMO
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 CMO
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Active Pharmaceutical Ingredients Market, By Application
8.1 Key application trends
8.2 Humans
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Veterinary
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Active Pharmaceutical Ingredients Market, By Drug Type
9.1 Key drug type trends
9.2 Prescription
9.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.3 OTC
9.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 10 Active Pharmaceutical Ingredients Market, By Region
10.1 Key regional trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Switzerland
10.3.2 France
10.3.3 Italy
10.3.4 Germany
10.3.5 UK
10.3.6 Spain
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Vietnam
10.4.7 Indonesia
10.4.8 Thailand
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Colombia
10.5.5 Chile
10.5.6 Peru
10.6 MEA
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Qatar
10.6.5 Bahrain
10.6.6 Egypt
Chapter 11 Company Profiles
11.1 Merck & Co., Inc.
11.2 Aarti Drugs Ltd
11.3 Biocon Ltd.
11.4 Qilu Pharmaceutical Co., Ltd.
11.5 Divi's Laboratories Limited
11.6 EUROAPI
11.7 Hikal Ltd.
11.8 Teva Pharmaceutical Industries Ltd
11.9 Cipla Ltd.
11.10 Neuland Laboratories Ltd.
11.11 Aurobindo Pharma Ltd
11.12 Sun Pharmaceutical Industries Ltd.
11.13 Dr. Reddy’s Laboratories Ltd
11.14 Pfizer, Inc
11.15 Solara Active Pharma
11.16 Alivira Animal Health Ltd
11.17 SUANFARMA
11.18 Procyon Life Sciences
11.19 NGL Fine-Chem Ltd
11.20 Ofichem Group
Data Tables
TABLE 1. Product mapping:
TABLE 2. Market revenue, by therapeutic category (2022):
TABLE 3. Market revenue, by synthesis type (2022):
TABLE 4. Market share, by contract outsourcing type (2022):
TABLE 5. Market share, by application (2022):
TABLE 6. Market share, by drug type (2022):
TABLE 7. Market share, by region (2022):
TABLE 8. Global active pharmaceutical ingredients market, 2018 - 2024 (USD Million)
TABLE 9. Global active pharmaceutical ingredients market, 2025 - 2032 (USD Million)
TABLE 10. Global active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024 (USD Million)
TABLE 11. Global active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032 (USD Million)
TABLE 12. Global active pharmaceutical ingredients market, by synthesis type, 2018 - 2024 (USD Million)
TABLE 13. Global active pharmaceutical ingredients market, by synthesis type, 2025 - 2032 (USD Million)
TABLE 14. Global active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024 (USD Million)
TABLE 15. Global active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032 (USD Million)
TABLE 16. Global active pharmaceutical ingredients market, by application, 2018 - 2024 (USD Million)
TABLE 17. Global active pharmaceutical ingredients market, by application, 2025 - 2032 (USD Million)
TABLE 18. Global active pharmaceutical ingredients market, by drug type, 2018 - 2024 (USD Million)
TABLE 19. Global active pharmaceutical ingredients market, by drug type, 2025 - 2032 (USD Million)
TABLE 20. Global active pharmaceutical ingredients market, by region, 2018 - 2024 (USD Million)
TABLE 21. Global active pharmaceutical ingredients market, by region, 2025 - 2032 (USD Million)
TABLE 22. Industry impact forces
TABLE 23. Comprehensive study of API supply chain of the U.S. and Europe
TABLE 24. APIs under development for the manufacturing of drugs
TABLE 25. Application of GMP guidance to API manufacturing
TABLE 26. Oncology market, 2018 - 2024 (USD Million)
TABLE 27. Oncology market, 2025 - 2032 (USD Million)
TABLE 28. Infectious diseases market, 2018 - 2024 (USD Million)
TABLE 29. Infectious diseases market, 2025 - 2032 (USD Million)
TABLE 30. Anti-diabetics market, 2018 - 2024 (USD Million)
TABLE 31. Anti-diabetics market, 2025 - 2032 (USD Million)
TABLE 32. CNS & anesthesia market, 2018 - 2024 (USD Million)
TABLE 33. CNS & anesthesia market, 2025 - 2032 (USD Million)
TABLE 34. Cardiovascular diseases market, 2018 - 2024 (USD Million)
TABLE 35. Cardiovascular diseases market, 2025 - 2032 (USD Million)
TABLE 36. Biologics market, 2018 - 2024 (USD Million)
TABLE 37. Biologics market, 2025 - 2032 (USD Million)
TABLE 38. Others market, 2018 - 2024 (USD Million)
TABLE 39. Others market, 2025 - 2032 (USD Million)
TABLE 40. Chemical based API market, 2018 - 2024 (USD Million)
TABLE 41. Chemical based API market, 2025 - 2032 (USD Million)
TABLE 42. Biological API market, 2018 - 2024 (USD Million)
TABLE 43. Biological API market, 2025 - 2032 (USD Million)
TABLE 44. Highly potent API (HPAPI) market, 2018 - 2024 (USD Million)
TABLE 45. Highly potent API (HPAPI) market, 2025 - 2032 (USD Million)
TABLE 46. CDMO market, 2018 - 2024 (USD Million)
TABLE 47. CDMO market, 2025 - 2032 (USD Million)
TABLE 48. CMO market, 2018 - 2024 (USD Million)
TABLE 49. CMO market, 2025 - 2032 (USD Million)
TABLE 50. Humans market, 2018 - 2024 (USD Million)
TABLE 51. Humans market, 2025 - 2032 (USD Million)
TABLE 52. Veterinary market, 2018 - 2024 (USD Million)
TABLE 53. Veterinary market, 2025 - 2032 (USD Million)
TABLE 54. Prescription market, 2018 - 2024 (USD Million)
TABLE 55. Prescription market, 2025 - 2032 (USD Million)
TABLE 56. OTC market, 2018 - 2024 (USD Million)
TABLE 57. OTC market, 2025 - 2032 (USD Million)
TABLE 58. North America active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
TABLE 59. North America active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
TABLE 60. North America active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 61. North America active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 62. North America active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 63. North America active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 64. North America active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 65. North America active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 66. North America active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 67. North America active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 68. North America active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 69. North America active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 70. U.S. active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 71. U.S. active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 72. U.S. active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 73. U.S. active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 74. U.S. active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 75. U.S. active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 76. U.S. active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 77. U.S. active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 78. U.S. active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 79. U.S. active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 80. Canada active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 81. Canada active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 82. Canada active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 83. Canada active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 84. Canada active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 85. Canada active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 86. Canada active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 87. Canada active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 88. Canada active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 89. Canada active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 90. Europe active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
TABLE 91. Europe active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
TABLE 92. Europe active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 93. Europe active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 94. Europe active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 95. Europe active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 96. Europe active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 97. Europe active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 98. Europe active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 99. Europe active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 100. Europe active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 101. Europe active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 102. Switzerland active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 103. Switzerland active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 104. Switzerland active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 105. Switzerland active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 106. Switzerland active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 107. Switzerland active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 108. Switzerland active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 109. Switzerland active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 110. Switzerland active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 111. Switzerland active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 112. France active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 113. France active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 114. France active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 115. France active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 116. France active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 117. France active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 118. France active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 119. France active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 120. France active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 121. France active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 122. Italy active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 123. Italy active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 124. Italy active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 125. Italy active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 126. Italy active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 127. Italy active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 128. Italy active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 129. Italy active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 130. Italy active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 131. Italy active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 132. Germany active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 133. Germany active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 134. Germany active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 135. Germany active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 136. Germany active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 137. Germany active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 138. Germany active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 139. Germany active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 140. Germany active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 141. Germany active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 142. UK active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 143. UK active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 144. UK active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 145. UK active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 146. UK active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 147. UK active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 148. UK active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 149. UK active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 150. UK active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 151. UK active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 152. Spain active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 153. Spain active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 154. Spain active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 155. Spain active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 156. Spain active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 157. Spain active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 158. Spain active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 159. Spain active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 160. Spain active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 161. Spain active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 162. Asia Pacific active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
TABLE 163. Asia Pacific active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
TABLE 164. Asia Pacific active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 165. Asia Pacific active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 166. Asia Pacific active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 167. Asia Pacific active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 168. Asia Pacific active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 169. Asia Pacific active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 170. Asia Pacific active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 171. Asia Pacific active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 172. Asia Pacific active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 173. Asia Pacific active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 174. China active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 175. China active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 176. China active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 177. China active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 178. China active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 179. China active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 180. China active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 181. China active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 182. China active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 183. China active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 184. Japan active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 185. Japan active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 186. Japan active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 187. Japan active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 188. Japan active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 189. Japan active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 190. Japan active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 191. Japan active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 192. Japan active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 193. Japan active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 194. India active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 195. India active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 196. India active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 197. India active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 198. India active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 199. India active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 200. India active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 201. India active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 202. India active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 203. India active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 204. Australia active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 205. Australia active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 206. Australia active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 207. Australia active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 208. Australia active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 209. Australia active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 210. Australia active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 211. Australia active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 212. Australia active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 213. Australia active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 214. South Korea active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 215. South Korea active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 216. South Korea active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 217. South Korea active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 218. South Korea active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 219. South Korea active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 220. South Korea active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 221. South Korea active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 222. South Korea active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 223. South Korea active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 224. Vietnam active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 225. Vietnam active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 226. Vietnam active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 227. Vietnam active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 228. Vietnam active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 229. Vietnam active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 230. Vietnam active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 231. Vietnam active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 232. Vietnam active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 233. Vietnam active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 234. Indonesia active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 235. Indonesia active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 236. Indonesia active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 237. Indonesia active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 238. Indonesia active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 239. Indonesia active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 240. Indonesia active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 241. Indonesia active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 242. Indonesia active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 243. Indonesia active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 244. Thailand active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 245. Thailand active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 246. Thailand active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 247. Thailand active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 248. Thailand active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 249. Thailand active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 250. Thailand active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 251. Thailand active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 252. Thailand active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 253. Thailand active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 254. Latin America active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
TABLE 255. Latin America active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
TABLE 256. Latin America active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 257. Latin America active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 258. Latin America active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 259. Latin America active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 260. Latin America active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 261. Latin America active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 262. Latin America active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 263. Latin America active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 264. Latin America active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 265. Latin America active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 266. Brazil active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 267. Brazil active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 268. Brazil active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 269. Brazil active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 270. Brazil active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 271. Brazil active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 272. Brazil active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 273. Brazil active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 274. Brazil active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 275. Brazil active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 276. Mexico active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 277. Mexico active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 278. Mexico active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 279. Mexico active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 280. Mexico active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 281. Mexico active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 282. Mexico active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 283. Mexico active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 284. Mexico active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 285. Mexico active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 286. Argentina active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 287. Argentina active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 288. Argentina active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 289. Argentina active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 290. Argentina active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 291. Argentina active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 292. Argentina active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 293. Argentina active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 294. Argentina active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 295. Argentina active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 296. Colombia active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 297. Colombia active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 298. Colombia active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 299. Colombia active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 300. Colombia active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 301. Colombia active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 302. Colombia active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 303. Colombia active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 304. Colombia active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 305. Colombia active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 306. Chile active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 307. Chile active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 308. Chile active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 309. Chile active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 310. Chile active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 311. Chile active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 312. Chile active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 313. Chile active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 314. Chile active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 315. Chile active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 316. Peru active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 317. Peru active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 318. Peru active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 319. Peru active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 320. Peru active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 321. Peru active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 322. Peru active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 323. Peru active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 324. Peru active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 325. Peru active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 326. MEA active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
TABLE 327. MEA active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
TABLE 328. MEA active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 329. MEA active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 330. MEA active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 331. MEA active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 332. MEA active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 333. MEA active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 334. MEA active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 335. MEA active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 336. MEA active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 337. MEA active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 338. South Africa active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 339. South Africa active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 340. South Africa active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 341. South Africa active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 342. South Africa active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 343. South Africa active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 344. South Africa active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 345. South Africa active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 346. South Africa active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 347. South Africa active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 348. Saudi Arabia active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 349. Saudi Arabia active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 350. Saudi Arabia active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 351. Saudi Arabia active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 352. Saudi Arabia active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 353. Saudi Arabia active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 354. Saudi Arabia active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 355. Saudi Arabia active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 356. Saudi Arabia active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 357. Saudi Arabia active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 358. UAE active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 359. UAE active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 360. UAE active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 361. UAE active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 362. UAE active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 363. UAE active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 364. UAE active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 365. UAE active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 366. UAE active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 367. UAE active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 368. Qatar active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 369. Qatar active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 370. Qatar active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 371. Qatar active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 372. Qatar active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 373. Qatar active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 374. Qatar active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 375. Qatar active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 376. Qatar active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 377. Qatar active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 378. Bahrain active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 379. Bahrain active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 380. Bahrain active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 381. Bahrain active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 382. Bahrain active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 383. Bahrain active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 384. Bahrain active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 385. Bahrain active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 386. Bahrain active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 387. Bahrain active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
TABLE 388. Egypt active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
TABLE 389. Egypt active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
TABLE 390. Egypt active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
TABLE 391. Egypt active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
TABLE 392. Egypt active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
TABLE 393. Egypt active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
TABLE 394. Egypt active pharmaceutical ingredients market, by application, 2018 - 2024, (USD Million)
TABLE 395. Egypt active pharmaceutical ingredients market, by application, 2025 - 2032, (USD Million)
TABLE 396. Egypt active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
TABLE 397. Egypt active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
Charts & Figures
FIG. 1 GMI report coverage: Critical research elements
FIG. 2 Industry segmentation
FIG. 3 Top-down approach
FIG. 4 Market estimation and forecast methodology
FIG. 5 Market forecasting methodology
FIG. 6 Impact of COVID-19
FIG. 7 Breakdown of primary participants
FIG. 8 Active pharmaceutical ingredients industry 3600 synopsis, 2018 - 2032
FIG. 9 Industry landscape, 2018 - 2032 (USD Million)
FIG. 10 U.S. loss of exclusivity, 2021-2028
FIG. 11 Growth potential analysis, by therapeutic category
FIG. 12 Growth potential analysis, by synthesis type
FIG. 13 Growth potential analysis, by contract outsourcing type
FIG. 14 Growth potential analysis, by application
FIG. 15 Growth potential analysis, by drug type
FIG. 16 Supply chain based on traditional API manufacturing
FIG. 17 Major Countries with API manufactures
FIG. 18 Share Of Supply in (%) Total European Demand in Tons
FIG. 19 Overview of CEPS, APIs AND MANUFACTURERS By Region (2000 – 2020)
FIG. 20 Overview of development of the number of valid CEPS (2000 – 2020)
FIG. 21 Overview of global distribution of currently valid CEPS (2020)
FIG. 22 Porter’s analysis
FIG. 23 PESTEL analysis
FIG. 24 Company matrix analysis, 2021
FIG. 25 Strategy dashboard, 2021
FIG. 26 Strategy landscape